Furthermore, Yigit et al. has shown that the administration of SLAMF6 antibodies in combination with the BTK kinase inhibitor Ibrutinib has a positive effect on depleting leukemia cells from mice [33]. The gene discussed is SLAMF6; the disease is leukemia.